Call for action on labelling of biosimilars

posted 26/09/2014

European trade association, the European Association for Bioindustry (EuropaBio) has called on the European Medicines Agency (EMA) to define specific guidanc...

The ethics of generic immunosuppressive drugs Generics/Research | Posted 26/09/2014
Amgen starts phase III trial for biosimilar rit... Biosimilars/News | Posted 26/09/2014
Phase III trials for generic asthma inhaler and... Generics/News | Posted 26/09/2014
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 26/09/2014
Roche updates position on biosimilars Biosimilars/News | Posted 26/09/2014
Generics taskforce for Australia Generics/General | Posted 26/09/2014
Strategy for biosimilars in China Biosimilars/Research | Posted 26/09/2014
Biosimilars of trastuzumab Biosimilars/General | Posted 19/09/2014
Pegfilgrastim biosimilar approved in South Korea Biosimilars/News | Posted 19/09/2014
FDA approvals for generic AIDs and testosterone... Generics/News | Posted 19/09/2014
Patient access to rituximab in emerging markets Biosimilars/Research | Posted 19/09/2014
Generics applications under review by EMA – Aug... Generics/General | Posted 19/09/2014
Biosimilars in emerging markets Reports | Posted 19/09/2014
Cipla and S&D Pharma make generics deal for... Pharma News | Posted 19/09/2014
Regulating the safety of biosimilars Biosimilars/Research | Posted 12/09/2014
FDA debuts purple book for biologicals and inte... Biosimilars/General | Posted 12/09/2014
Pharma’s future in China and the US Generics/Research | Posted 12/09/2014
European approval for biosimilar insulin Biosimilars/News | Posted 12/09/2014
Generic hepatitis drug to be made available to... Generics/General | Posted 12/09/2014
Teva wins another Symbicort patent challenge Generics/News | Posted 12/09/2014
Patients at risk from UK drug shortages Pharma News | Posted 12/09/2014
Generics group calls for say on ICH standards Guidelines | Posted 12/09/2014
Appropriate generics pricing improves medicines... Generics/Research | Posted 05/09/2014
Adalimumab biosimilar has comparable pharmacoki... Biosimilars/Research | Posted 05/09/2014
FDA accepts applications for three-times-weekly... Generics/News | Posted 05/09/2014
Infliximab biosimilar to be distributed by Mund... Biosimilars/News | Posted 05/09/2014
Generics makers comment on draft ANDA guidance Guidelines | Posted 05/09/2014
US senators call for guidance on biosimilars Biosimilars/General | Posted 05/09/2014
Generics companies sue Reckitt Benckisser over... Generics/News | Posted 05/09/2014
The future of biosimilar use and regulation in... Biosimilars/Research | Posted 29/08/2014
Value of generics overlooked in one country tha... Generics/Research | Posted 29/08/2014
Physicians believe biosimilars should have diff... Biosimilars/General | Posted 29/08/2014
FDA receives application for monoclonal antibod... Biosimilars/News | Posted 29/08/2014
Idaho proposes legislation on biosimilars subst... Policies & Legislation | Posted 29/08/2014
Lawyers look at new price hike for old drug Generics/General | Posted 29/08/2014
US court puts generic Gralise on hold Generics/News | Posted 29/08/2014
Trends in the financial burden of diabetes trea... Generics/Research | Posted 22/08/2014
FDA grants tentative approval for insulin treat... Biosimilars/News | Posted 22/08/2014
ECCO survey highlights lack of confidence in bi... Biosimilars/Research | Posted 22/08/2014
Generics shortages continue to rise in the UK Pharma News | Posted 22/08/2014
Generics manufacturers focus on MS drug Ampyra Generics/News | Posted 22/08/2014
More biosimilars collaborations on the cards Biosimilars/News | Posted 22/08/2014
Ranbaxy’s manufacturing woes benefit big pharma Generics/General | Posted 22/08/2014
WHO proposal offers clarity for biosimilar nome... Biosimilars/General | Posted 14/08/2014
Biosimilar events from 2012 to 2014 Reports | Posted 14/08/2014

Generics News Research General


Biosimilars News Research General